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Abstract
Background: The objective of this study was to demonstrate the anti-skin cancer and chemopreventive potential of 1,1-
bis(39-indolyl)-1-(p-chlorophenyl methane) (DIM-D) using an in vitro model.
Methods: In vitro cell cytotoxicity and viability assays were carried out in A431 human epidermoid carcinoma cell line and
normal human epidermal keratinocytes (NHEK) respectively by crystal violet staining. Apoptosis induction in A431 cells
(DIM-D treated) and NHEK cells pretreated with DIM-D (2 hr) prior to UVB irradiation, were assessed. The accumulation of
reactive oxygen species (ROS) in DIM-D pretreated NHEK cells (2 hr) prior to UVB exposure was also determined.
Immunocytochemistry and western blot analysis was performed to determine cleaved caspase 3 and DNA damage markers
in DIM-D treated A431 cells and in DIM-D pretreated NHEK cells prior to UVB irradiation.
Results: The IC50 values of DIM-D were 68.767.3, 48.3610.1 and 11.563.1 mM whilst for Epigallocatechin gallate (EGCG)
were 419.168.3, 186.165.2 and 56.763.1 mM for 24, 48 and 72 hr treatments respectively. DIM-D exhibited a significantly
(p,0.05) greater induction of DNA fragmentation in A431 cells compared to EGCG with percent cell death of 38.9. In
addition, DIM-D induced higher expression in A431 cells compared to EGCG of cleaved caspase 3 (3.0-fold vs. 2.4-fold
changes), Nurr1 (2.7-fold vs. 1.7-fold changes) and NFkB (1.3-fold vs. 1.1-fold changes). DIM-D also exhibited
chemopreventive activity in UVB-irradiated NHEK cells by significantly (p,0.05) reducing UVB-induced ROS formation
and apoptosis compared to EGCG. Additionally, DIM-D induced expression of Nurr1 but reduced expression of 8-OHdG
significantly in UVB-irradiated NHEK cells compared to EGCG and UV only.
Conclusion: Our results suggest that DIM-D exhibits Nurr1-dependent transactivation in the induction of apoptosis in A431
cells and it protects NHEK cells against UVB-induced ROS formation and DNA damage.
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Introduction
Skin cancer incidence has been increasing and over 2 million
new cases are diagnosed each year in the United States [1]. It has
been estimated that one in five Caucasian Americans will develop
skin cancer at least once in the course of his/her lifetime [2].
Melanoma is the most severe form of skin cancer and accounts for
5% of all skin cancer cases in America, is responsible for most skin
cancer deaths [3][4], with an impact estimated at $2.36 billion in
2010 [5]. The increasing incidence of skin cancer is expected to
continue as the population ages, greater amounts of UV radiation
reach the surface of the earth due to depletion of the ozone layer,
and continuous use of sun tanning devices [6][7][8].
Studies have shown that persistent exposure to sunlight is an
important risk factor for development of both nonmelanoma skin
cancer (NMSC) and melanoma due to injurious effects of UVB
radiation that breaches the epidermal layer of the skin [9][10].
The initiation and progression of skin carcinogenesis involves a
complex cascade of cellular and molecular events ensuing from the
initial production of reactive oxygen species (ROS) by UVB
radiation [11][12][13] and results in keratinocyte DNA damage
and mutation including the formation of cyclobutane pyrimidine
dimers (CPD). Studies have shown that there is also substantial
damage caused to the skin lipids and proteins upon UVB exposure
[14][15].
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Many phytochemicals and synthetic analogs have the ability to
reverse and/or decrease the onset and progression of skin
carcinogenesis and angiogenesis [16][17]. These phytochemicals
are primarily polyphenols, which include but are not limited to
silymarin, epigallocatechin 3-gallate (EGCG), curcumin, myrice-
tin, quercetin and hesperitin. EGCG is an abundant polyphenol
present in green tea extract and is a potent antioxidant flavonoid
that has chemopreventive potential [18]. EGCG can induce cell
cycle arrest and apoptosis in hepatoma cells by inducing p53 and
Fas/FasL apoptotic pathway respectively [19]. The cytotoxicity of
EGCG in vitro requires relatively high concentrations [20] that
are not readily achieved in the serum and both oral and topical
formulations of EGCG exhibit minimal protection against
photoaging and UV-induced inflammatory responses in the skin
[21][22][23].
3,39-Diindolylmethane (DIM) (Fig. S1) is a natural product
derived from indole-3-carbinol (I3C) which is present in crucifer-
ous vegetables such as brussels sprouts, broccoli and cauliflower.
DIM has generated much interest in cancer research because of its
low toxicity and cytotoxic effects on cancer cells in vitro and
inhibition of tumor growth in vivo [24]. For example, DIM
induced expression of cell cycle inhibitors such as p21 and p27 and
downregulated-cyclin proteins including cyclin D1 and also
decreased expression of survival and antiapoptotic proteins
including survivin, bcl-2, bax and induced poly (ADP-Ribose)
polymerase (PARP) cleavage, mitochondrial cytochrome c release
and procaspase cleavage [25][26][27]. A series of novel synthetic
1,1-bis(39-indolyl)-1-(p-substituted phenyl) methane analogs (C-
DIMs), are also potent anticancer agents [25][28][29] and their
activities are structure-dependent. The p-t-butylphenyl and p-
biphenyl derivatives activate peroxisome proliferator-activated
receptor c (PPARc) whereas the unsubstituted p-phenyl and p-
methoxyphenyl analogs activate the orphan receptor NR4A1
(Nurr77/TR3) [30]. Studies in our laboratory have reported a
synergistic effect between 1,1-bis(39-indolyl)-1-(p-biphenyl) meth-
ane (DIM-C-pPhC6H5) and Docetaxel in non-small cell lung
cancer cells through enhanced induction of cleaved PARP, bax
and N-cadherin and inhibition of phospho-Akt, cyclin D1,
survivin, NF-kB, Mcl-1 and phospho JNK2 [29][31].
A member of the nerve growth factor I-B Nurr1 (NR4A2) is
another NR4A receptor, which has been implicated, in various
hormonal, physiological and pathophysiological processes includ-
ing cardiovascular, neurological and metabolic diseases, inflam-
mation and oncogenesis. Nurr1 plays a role in brain function and
hence has been linked to Alzheimer’s disease, Schizophrenia and
Parkinson’s disease [32]. Nurr1 is highly expressed in Panc1 and
Pan28 pancreatic and some human bladder cancer cell lines
[28][33]. In this study, we illustrate the significance of Nurr1 in the
chemopreventive potential of 1,1-bis(39-indolyl)-1-(p-chlorophenyl
methane) (DIM-D) in skin cancer using an in vitro UVB induced
skin cancer model. DIM-D has shown to induce Nurr1-dependent
transactivation and results of our study suggest a possible role for
DIM-D/Nurr1 in chemoprevention of skin cancer.
Materials and Methods
1. Materials
p-Substituted C-DIM analogs (DIM-C-pPhCl; DIM-D), (DIM-
C-pPhCN; DIM-B) and (DIM-C-pPhBr; DIM-C) were synthe-
sized as described [36]. EGCG was purchased from Selleck
Chemicals (Houston, TX, USA). A431 human epidermoid
carcinoma cell line and normal human epidermal keratinocytes
(NHEK) were acquired from Invitrogen (Grand Island, NY, USA).
Phosphate buffered saline (PBS) was purchased from Invitrogen.
The NR4A2 (Nurr 1) antibody was obtained from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA). The antibodies directed
against 8-hydroxy deguanosine (8-OHdG), CCAAT/-enhancer-
binding protein homologous protein (CHOP), nuclear factor
kappa-light-chain-enhancer of activated B cells (NF-kB) and
cleaved caspase 3 were also obtained from Santa Cruz Biotech-
nology, Inc. (Santa Cruz, CA).
2. Cell lines and cell cultures
A431 cells were maintained in Dulbecco’s modified Eagle’s
medium (DMEM; Sigma Aldrich, St Louis, MO) nutrient mixture
supplemented with 10% fetal bovine serum (FBS) from Invitrogen
(Grand Island, NY) and antibiotic-antimycotic mixture comprising
penicillin (5000 U/mL), streptomycin (0.1 mg/mL), and neomy-
cin (0.2 mg/mL) from Sigma Aldrich (St Louis, MO, USA) at
37uC in the presence of 5% CO2 and 95% relative humidity.
NHEK cells were maintained in Epilife medium (Invitrogen,
Grand Island, NY, USA) and were sustained by either epidermal
growth supplement (EDGS) or human keratinocyte growth
supplement (HKGS) from Invitrogen (Grand Island, NY) and
antibiotic-antimycotic mixture comprising penicillin (5000 U/mL),
streptomycin (0.1 mg/mL), and neomycin (0.2 mg/mL) from
Sigma Aldrich (St Louis, MO) at 37uC. Both cells lines were sub
cultured when approximately 80–90% confluent with 0.25%
trypsin-EDTA (Invitrogen; Grand Island, NY). The cells were
cultivated on 1.12 cm2 0.4 mm pore polycarbonate membrane
inserts in 12 mm612-transwell permeable support plates
(Corning, NY).
3. In vitro Cell Cytotoxicity and Viability Assays
Cell cytotoxicity and cell viability assays were carried out in
A431 and NHEK cells respectively using the conventional crystal
violet staining assay. The A431 and NHEK cells were both seeded
in 96-well plates (104 cells/well) and incubated overnight in 5%
CO2 at 37uC. The A431 cells were treated with the solvent control
(DMSO) and various concentrations of DIM-B, DIM-C and DIM-
D and EGCG, whilst NHEK cells were exposed to UVB radiation
(150 J/m2) 2 hr following treatment and then incubated for 24 hr
in growth media. The A431 cells in drug and media mixture were
incubated for 24, 48 and 72 hr. The viable cells were fixed with
glutaraldehyde and stained with crystal violet for 15 min at room
temperature. The crystal violet was washed; the residue solubilized
with sodium hydrogen phosphate and the absorbance was
measured with a spectrophotometer at wavelength of 462 nm.
Viability of NHEK cells treated with C-DIMs or EGCG were
expressed as percentages of the absorbance of control cells, which
were regarded as 100% viable and IC50 values were determined
by the following formula, [(50– lowest kill)/(highest kill – lowest
kill) * (highest conc. – lowest conc.)] + lowest conc.
4. TUNEL Assay
A431 cells were treated with 34.4 mM DIM-D (50 percent of
IC50 value) and incubated for 24 hr. Cells were then washed with
PBS buffer and fixed in 10% formaldehyde on microscopic sides.
The ApoTag Red In Situ Apoptosis detection kitH (Millipore,
Billerica, MA) was used for the detection of apoptosis in
accordance with the manufacturer’s protocol. Briefly, the fixed
cells were incubated in 20 mg/mL proteinase K solution for
15 min at room temp, followed by incubation with equilibration
buffer for 10 sec. The cells were washed in PBS and incubated
with TdT enzyme at 37uC for 1 hr in a humidified chamber for
incorporation of conjugated nucleotides at the 39-OH ends of
DNA. The fixed cells were washed in PBS and incubated with
anti-digoxigenin conjugate (Rhodamine Antibody) solution and
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counterstained with DAPI. The microscopic images of the fixed
cells on the slides were visualized with an Olympus BX40 light
microscope equipped with a computer-controlled digital camera
(DP71, Olympus Center Valley, PA, USA). DNA fragmentation
was indicated by Rhodamine positive staining (red). Untreated
cells were maintained as control.
5. Acridine orange/ethidium bromide staining
Morphological changes in NHEK cell nuclei following exposure
to UVB radiation was determined to assess the protective effects of
DIM-D and EGCG in the exposed cells. Cells were seeded in 96-
well plate (104 cells/well) and treated for 2 hr with different
concentrations of solutions of DIM-D and EGCG in DMSO prior
to UVB radiation exposure at dose of 150 mJ for 30 sec. Cells
were then incubated in growth media for 24 hr and staining was
carried out with acridine orange/ethidium bromide (AO/EB) as
described [34] and analyzed by fluorescence microscopy. Briefly,
the differential uptake of the two dyes was used to ascertain cells
viability. After incubation for 24 hr, cells were washed with PBS
(2X) and stained with a mixture of acridine orange and ethidium
bromide.
6. Determination of intracellular reactive oxygen species
(ROS)
The fluorescent dye, 29,79-dichlorofluorescein diacetate (DCF-
DA) was used to assess the accumulation of ROS in NHEK cells
after UVB exposure. Cells were seeded in a 24-well plate at a
density of 0.056106 cells/well, treated with different concentra-
tions of DIM-D and EGCG in DMSO for 2 hr, aspirated a thin
film of PBS was added and cells were then exposed to UVB
radiation dose of 150 mJ for 30 sec. Cells were then incubated for
24 hr in growth media only. DCF-DA solution (10 mM) was added
to the cells (0.056106/mL) and the mixture incubated at 37uC for
1 hr in the dark. Cells were washed with PBS (2X) and the
fluorescence intensity of the cells was determined by fluorescence
microscopy.
7. Immunocytochemical analysis
Both A431 and NHEK cells were treated with DIM-D and
EGCG (34.4 mM and 210.0 mM respectively) and incubated for
24 hr. Cells were then fixed in 10% formaldehyde and cytospun
into microscopic slides. The analysis was carried out following the
protocol specified in the SignalStainTM IHC kit (Cell Signaling,
Beverly, MA). Fixed cells were hydrated with varying concentra-
tions of alcohol and PBS (3X), incubated with the primary
antibodies against cleaved caspase 3, Nurr1 and 8-OHdG
overnight at 4uC and detected by HRP-conjugated secondary
antibody. Cells were stained with Nova Red stain and counter-
stained with hematoxylin. Microscopic analysis of the fixed cells
was carried out with an Olympus BX40 light microscope equipped
with computer-controlled digital camera (DP71, Olympus Center
Valley, PA, USA).
8. Western blot analysis
Proteins were collected from both A431 and NHEK cells as
described [33]. Briefly, after 24 hr treatment with DIM-D
(17.2 mM) and EGCG (104.8 mM), cells were treated with RIPA
buffer (50 nM Tris-HCl, pH 8.0, with 150 mM sodium chloride,
1.0% Igepal CA-630 (NP-40), 0.5% sodium deoxychlorate, and
0.1% sodium dodecyl sulfate) with protease inhibitor (500 mM
phenylmethylsulfonyl fluoride). Protein concentrations were de-
termined according to BCA protein assay reagent protocol
(PIERCE, Rockford, IL) and the standard plot was generated by
using bovine serum albumin, 50 mg of supernatant protein from
the control group and all the different treatment samples were
denatured by boiling at 100uC for 5 min in SDS sample buffer and
were subsequently electrophoresed in 10% SDS-PAGE gel,
transferred into nitrocellulose membranes, blocked with 5% skim
milk in tris-buffered saline with tween 20 (10 mM tris-HCl (pH
7.6), 150 mM NaCl, and 0.5% Tween), and probed with
antibodies against Nurr1 (1:400), NFkB (1:500) and cleaved
caspase 3 (1:1000) for A431 cells. Proteins were detected with
HRP conjugated secondary antibodies using SuperSignal West
pico chemiluminescent solution (PIERCE, Rockford, IL). Quan-
tification and analysis of the results were carried out with Image J
software (v1.33u, NIH, USA). Results were expressed as percent-
age ratios of protein expression to b-actin (set to 100%).
9. Statistical analysis
Results are expressed as the mean 6 S.D for at least three
replicates and comparison between multiple groups was estab-
lished by a one-way analysis of variance (ANOVA) and between
two groups by student’s t test analysis. A p value ,0.05 was
considered significant.
Results
1. Anticancer activity of DIM analogues
1.1 Effect of DIM analogues on A431 skin cancer
cells. A431 cells were treated with three different DIM
analogues, which differ structurally at the p-phenyl position
(Fig. S1). A431 cells were treated with DIM-B for 24, 48 and 72 hr
and IC50 values for cytotoxicity were 56.8610.7, 30.866.6 and
7.261.2 mM respectively (Fig. 1A). The IC50 values for DIM-C
after treatment for 24, 48 and 72 hr were 78.3616, 50.2612.2
and 7.261.5 mM respectively and the corresponding IC50 values
for DIM-D were 68.7627.3, 48.3610.1and 11.563.1 mM after
treatment for 24, 48 and 72 hr. In contrast, IC50 values for
EGCG after treatment for 24, 48 and 72 hr were 419.168.3,
186.165.2 and 56.763.1 mM respectively (Fig. 1B), which were
significantly higher than observed for C-DIMs (Table 1). All three
DIM derivatives showed more potency than EGCG with little
variations between their potencies. DIM-D was however selected
for further studies as a model drug because it exhibited more
photostability than DIM-B and DIM-C.
1.2 Apoptotic activity of DIM-D against A431 cells. The
effects of DIM-D on apoptosis in A431 cells were examined by the
TUNEL method using flow cytometry. A431 cells treated with
DIM-D (34.4 mM) for 24 hr significantly induced cell death
(38.9%) compared to DMSO control (Fig. 2A). We also
investigated the effects of DIM-D and EGCG on DNA
fragmentation of A431 cells using TUNEL method by microscopic
analysis (Fig. 2B). In control cells treated with PBS, minimal DNA
fragmentation was observed whereas DIM-D significantly in-
creased DNA fragmentation as evidenced by increased red
fluorescence. Similarly, EGCG (104.8 mM) also increased DNA
fragmentation but comparatively less when compared with
DIM-D (Fig. 2B).
1.3 Effect of DIM-D on apoptotic proteins and
Nurr1. A431 cells were treated with 34.4 mM DIM-D and
104.8 mM EGCG for 24 hr and whole cell lysates were analyzed
by western blots (Fig. 3A). DIM-D significantly induced expression
of cleaved (activated) caspase-3 and Nurr1 proteins and similar
results were observed for EGCG. Quantitation of these results
(Fig. 3B) showed that DIM-D was more potent that EGCG as an
inducer of cleaved caspase-3 (3.0 fold vs 2.4 fold) and Nurr1 (2.7
fold vs 1.7 fold) whereas effects on NFkB (p65) were minimal (1.3
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fold vs 1.1 fold). Expression of cleaved caspase-3 and Nurr1 was
significantly induced by DIM-D and EGCG (p,0.05). DIM-D
(34.4 mM) and EGCG (104.8 mM) also induced CHOP expression
as indicated by immunostaining of A431 cells after treatment for
24 hr (Fig. 3C). Quantitation of these results showed significant
increase of CHOP positively stained cells (79%) in DIM-D treated
cells as compared to 67% of cells positively stained after EGCG
treatment. These results suggest that the anti-skin carcinogenic
potency of DIM-D is greater than EGCG under identical
conditions.
2. Chemopreventive activity of DIM-D on normal human
epidermal keratinocyte (NHEK) cells
2.1 Cytotoxic effect of DIM-D on NHEK cells. In order to
investigate the effects of DIM-D against normal skin cells, NHEK
cells were treated with various concentrations of DIM-D (15 to
140 mM) for 24 hr and results indicated that DIM-D was
minimally toxic to NHEK cells (Fig. 4A). At the maximum
concentration of 140 mM, percentage cell death was 56.261.3
whilst at the IC50 concentration (68.767.3 mM) observed in A431
cells, NHEK cell death was reduced to 48.762.1%. Hence,
concentration of DIM-D 68.767.3 mM was employed for all
subsequent investigations. On the other hand, exposure of the
pretreated NHEK cells to UV radiation, reduced cell viability
further. This was however not significant with increase in percent
cell death to 67.562.6 and 65.963.1 for 140 mM and 68.7 mM
respectively (Fig. 4A).
2.2 Anti-oxidant potential and apoptotic activity of DIM-D
on NHEK cells. The antioxidant activity of DIM-D and
protection against UV-induced ROS was also investigated in
NHEK cells treated with 34.4 mM DIM-D and 209.6 mM EGCG
for 24 hr. The UVB-induced ROS levels in NHEK cells
pretreated with DIM-D were significantly reduced compared to
EGCG; this demonstrates that DIM-D has more potent anti-
oxidant activity than EGCG (Fig. 4B). In addition, the ability of
DIM-D to scavenge hydroxyl (-OH) radicals in a cell-free in vitro
system was utilized to confirm the enhanced anti-oxidant potential
of DIM-D compared to EGCG. The results in Figure 4C revealed
that at concentrations of 34.4 mM to 280 mM, DIM-D was able to
quench approximately 30% to 90% of the hydroxyl radicals.
Next, apoptotic activity was analyzed in NHEK cells, which
were pretreated with EGCG (17.2 mM and 68.7 mM) and DIM-D
(8.6 and 34.4 mM) prior to UVB exposure. For efficient
comparison between EGCG and DIM-D with respect to
protection against apoptosis, the IC50 and one-fourth the IC50
concentrations of DIM-D were employed for EGCG pretreatment
of cells whilst half of the respective concentrations were employed
for DIM-D pretreatment. The acridine orange/ethidium bromide
double staining was utilized for the apoptotic assay because the
acridine orange dye has ability to stain the nuclei of viable cells
green whilst the ethidium dye, an intercalating agent permeated
apoptotic or necrotic cells to stain their nuclei orange. We
Figure 1. Cytotoxicity profile of DIM analogues and EGCG at different concentrations in A431 cells. (A) Cytotoxicity profile (Plot of %
cell death vs concentration of drug at A) 24 hr, B) 48 hr and C) 72 hr where, DIM-B = DIM-C-pPhCN, DIM-C =DIM-C-pPhBr and DIM-D = DIM-C-
pPhCl). Data represent mean 6 SD. (B) Cytotoxicity profile (Plot of % cell death vs concentration of drug) at A) 24 hr, B) 48 hr, C) 72 hr for EGCG in
A431 cells.
doi:10.1371/journal.pone.0069519.g001
Table 1. IC50 values of DIM-B (DIM-C-pPhCN), DIM-C (DIM-C-
pPhBr) and DIM-D (DIM-C-pPhCl) and ECGC at 24, 48 and
72 hr. Data represent mean 6 SD (n = 3).
Time (hr) IC50 values mM
DIM-B DIM-C DIM-D
Epigallocatechin
gallate (EGCG)
24 56.8610.7 78.3616.0 68.767.3 419.168.3
48 30.866.6 50.2612.2 48.3610.1 186.165.2
72 7.261.2 7.261.5 11.563.1 56.763.1
doi:10.1371/journal.pone.0069519.t001
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demonstrated that in cells, which were treated with DIM-D, there
was a significant reduction apoptotic cell death (red staining)
compared to cells treated with EGCG (Fig. 4D). No apoptotic cell
death was observed in the control cells, which were treated with
either PBS or vehicle only. DIM-D treatment caused significant
decrease in induction of apoptosis by UVB irradiation in NHEK
cells. EGCG, however, showed minimal protection of the cells
against apoptosis. The cells pretreated with EGCG prior to UVB
irradiation were markedly stained red by ethidium bromide.
Overall, these findings suggest that although there was reduction
in cell viability in DIM-D+UV treated cells compared to DIM-D
only treated cells (as shown in fig. 4A); DIM-D treatment relatively
prevents the induction of apoptosis by UVB radiation and hence
enhances cell viability more significantly than EGCG.
2.3 Effect of DIM-D on UVB-induced-oxidative
stress. To further investigate whether DIM-D inhibits UV
radiation-induced oxidative stress and inflammation through
enhancement of Nurr1 in UV-exposed skin cells, we examined
the expression of Nurr1 and 8-OHdG in NHEK cells (Fig. 5).
After UVB irradiation, cells were treated with DIM-D (34.4 mM)
and EGCG (209.6 mM) for 24 hr and formation of 8-OHdG was
determined by immunostaining (Fig. 5A). UVB significantly
increased 8-OHdG but both DIM-D and EGCG significantly
decreased the UVB-induced response thus confirming the
antioxidant activity of both compounds. Their relative potency
was evident by immunostaining. Only 3.6% of cells were positively
stained in DIM-D treatment as compared to EGCG treated cells
(20% cells).
Immunocytochemical analysis revealed that, the Nurr1 expres-
sion was significantly stronger as compared to EGCG and UV
only (Fig. 5A). Quantitation of these results showed that
approximately 83% of cells were positively stained for Nurr1 in
DIM-D treated cells as compared to EGCG treated cells (66%).
These results clearly demonstrated that DIM-D was more potent
that EGCG as an inducer of Nurr1. Further these results were
confirmed by western blot analysis. For this purpose, NHEK cells
Figure 2. Determination of apoptosis in A431 cells after treatment with DIM-D and EGCG by TUNEL assay. (A) Detection of apoptotic
cells by the TUNEL method using flow cytometric analysis. A431 cells were stained for apoptotic cells with FITC by the TUNEL method before and
after 24 hr treatment. (i) Dot plot depicting FSC versus SSC profile of cells after treatment. (ii) Dot plot depicting profile of FITC fluorescence versus
FSC for cells after treatment. Most of the TUNEL-stained apoptotic cells are slightly smaller than unstained live cells. (iii) Histogram depicting cells
before treatment in the gate R1. Very few apoptotic cells are detected. (iv) Histogram depicting cells after treatment with DIM-D (DIM-C-pPhCl) in the
gate R1. Apoptotic cells (brightly stained by TUNEL) are detected. (B) Detection of apoptotic cells by the TUNEL method using microscopic analysis.
A431 cells were stained for apoptotic cells with Rhodamine by the TUNEL method for 24-hr treatment. Cells were counterstained with Hoechst dye
(DAPI).
doi:10.1371/journal.pone.0069519.g002
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were treated with DIM-D (34.4 mM) and EGCG (209.6 mM) for
24 hr and whole cell lysates were analyzed (Fig. 5B). NHEK cells
treated with DIM-D showed Nurr1 expression was increased
significantly more in DIM-D treated cells (1.8 fold) as compared to
EGCG (1.4 fold) (Fig. 5C).
Discussion
Poor clinical outcome of the current treatment avenues has
prompted the need for the development of new therapeutic
strategies for treatment of skin cancer. There is an urgent need to
identify molecular targets using dietary compounds, which have
both therapeutic as well as chemopreventive activity. Nurr1 is an
orphan nuclear receptor and preliminary reports suggest a role for
Nurr1 in rheumatoid arthritis and cancer through modulation of
apoptosis. Further it has also been demonstrated that DIM
analogues activates the orphan nuclear receptor Nurr1 and
inhibits bladder cancer growth [28]. However there are no reports
on the chemopreventive potential of DIM-D activated Nurr1 in
skin cancer. Therefore, in the first part of present study we focused
on anticancer or therapeutic activity of DIM-D using A431 skin
cancer cells. In the second part of our study we investigated the
chemopreventive activity of DIM-D through Nurr1 mediated
signaling using NHEK.
In first part of our study, we assessed the cytotoxic effect of
DIM-D on A431 skin cells. It is important to point out that DIM-
D showed cytotoxic effect on these cells and its cytotoxic effect was
greater than EGCG. Similar to EGCG, previous studies have
demonstrated that DIM inhibits growth of cancer cells derived
from tumors of the prostate, breast, colon, cervix and pancreas
[34]. The role of apoptosis was further investigated by determining
expression of apoptotic protein such as cleaved caspase-3 in A431
cells. The western blot analysis showed significant increase in
expression of caspase-3 following DIM-D treatment in A431 cells.
We also studied DNA fragmentation in A431 cells after DIM-D
treatment because DNA fragmentation is a hallmark of apoptosis,
which commits cells to die. DNA fragmentation was highly
induced by DIM-D compared to EGCG, thus confirming that
apoptosis is an important pathway associated with the anticancer
activity of these compounds. This was well correlated with our
Figure 3. Determination of protein expression levels by western blot and immunocytochemistry. (A) Expression of cleaved caspase 3,
Nurr1 and NFkB in comparison to the control b-actin in Dim-D and EGCG treated A431 cells by western blot. Untreated cells were maintained as
control. (B) Western blot analysis of expression of different proteins increased significantly in DIM-D treated cells. (C) ICC peroxidase staining of A431
cells treated with DIM-D and EGCG, respectively for the pro-apoptotic protein, CHOP. Brown staining was considered positive result. Untreated cells
were maintained as control. Data are calculated from triplicate experiments and presented as mean, and error bars refer to SD, *P,0.05, **P,0.01
compared with control.
doi:10.1371/journal.pone.0069519.g003
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previous study of enhancement of anticancer activity by a DIM
compound in human non-small cell lung cancer cells [29].
Previous studies have shown that DIM-D activates endoplasmic
reticulum stress in pancreatic and ovarian cancer cells [35][36].
DIM-D induced expression of endoplasmic reticulum stress
protein GRP78 through enhanced expression of CHOP and this
was accompanied by inhibition of tumor growth [37]. Similarly,
our immunocytochemical studies showed that DIM-D increased
the expression of CHOP in A431 cells after treatment for 24 hr.
These results demonstrate that DIM-D exerts its anti-cancer
effects through targeting multiple molecular targets associated with
cell survival and apoptosis.
Overexpression of Nurr1 decreases inflammatory mediators,
scavenger receptor expression and lowers LDL accumulation in
macrophages [38][39]. In our study, expression of cleaved
caspase-3 was increased in A431 cells after DIM-D treatment.
The repression of inflammatory markers including NFkB provide
protection to normal cells from the damaging effects of UVB
irradiation [40] whilst on the other hand, their stimulation in
cancer cells can induce stress and subsequently, apoptosis. This is
in complete concordance with our study where we have shown the
pronounced upregulation of NFkB in A431 cancer cells treated
with DIM-D and to a lesser extent, in EGCG treated cells, all
compared to control. NFkB regulates the expression of genes
involved in many processes that play a key role in the development
and progression of cancer such as proliferation, migration and
apoptosis.
In second part of our study, we assessed the chemopreventive
effect of DIM-D in NHEK. For this purpose, cells were exposed to
UVB with and without treatment with DIM-D to examine the
cytotoxic effect. It is important to point out that DIM-D relatively
did not show cytotoxic effect on normal cells but after exposing
these cells to UVB, the viability of the cells were reduced further.
In spite of this observation, the acridine orange/ethidium bromide
double staining revealed the relative cytoprotective effect of DIM-
D in the NHEK cells compared to EGCG. Hence, though
percentage cell death increased with DIM-D+ UV treatment,
there was protection to an extent against induction of apoptosis in
these cells. Another explanation of this observation is the fact that
this effect of DIM-D on UVB-irradiated cells protects the
photodamaged cells from further proliferation, which may be
mutated or malignant. Thus, it shows the chemopreventive activity
of DIM-D. Excessive exposure of the skin to solar UV- radiation is
Figure 4. Effect of cytotoxicity, antioxidant potential and apoptosis in NHEK cells treated by DIM-D for 24 hr. (A) Line graph of
cytotoxicity profile (Plot of % cell death vs concentration of drug) of NHEK cells treated with DIM-D (DIM-C-pPhCl) at various concentrations with and
without UVB radiation. Data represent mean 6 SD. (B) Production of Reactive oxygen species (ROS) with DIM-D and EGCG treatment prior to UVB
exposure. Each value is expressed as the mean6 standard deviation. (C) Hydroxyl radical scavenging in an in vitro cell-free system treatment by DIM-
D. The data is expressed in terms of percentage of control in which the cell-free system was not treated with DIM-D. (D) Apoptosis determination in
NHEK cells treated with DIM-D (DIM-C-pPhCl) and EGCG at different concentrations.
doi:10.1371/journal.pone.0069519.g004
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one of the major etiologic factors for the development of skin
cancer.
Hence, after exposing NHEK cells to UVB radiation, we
investigated the antioxidant potential of DIM-D. Here we also
used EGCG because of its known anticarcinogenic and antioxi-
dant activities [41]. The present study demonstrates that DIM-D
and EGCG reduced ROS levels in UVB irradiated NHEK cells.
The induction of oxidative stress also overwhelms the antioxidant
defense ability of the cutaneous system and leads to the onset of
several disease states including skin cancer or photocarcinogenesis
and photoaging [42]. It was reported that dietary grape seed
proanthocyanidins also inhibit UVB-induced photocarcinogenesis
in mice by reducing the levels of UVB-induced oxidative stress
[43]. In our study, the hydroxyl radical scavenging activity of
DIM-D in an in vitro cell-free system was pronounced suggesting
that the DIM-D will protect normal skin against UVB induced
oxidative stress, which leads to photocarcinogenesis. Our results
were consistent with Wiseman et al [44] who demonstrated that
green tea extract effectively scavenged superoxide free radicals,
hydroxyl radicals and prevented Cu-mediated LDL oxidation.
The anti-oxidant effect of DIM-D was however superior to EGCG
because treatment with DIM-D scavenged more hydroxyl radicals
as compared with EGCG.
To investigate the possible involvement of apoptosis in the
chemopreventive effects of DIM-D, we examined apoptosis in
UVB irradiated NHEK cells after DIM-D treatment. Our results
demonstrated that in UVB irradiated NHEK cells; apoptosis was
low as compared to EGCG showing its chemopreventive activity
was superior to that of EGCG. EGCG has been reported to have
anticancer activity in various cancers and demonstrated that
EGCG inhibited the growth of squamous carcinoma cell’s via S
and G(2)/M phase arrest [45]. Although the molecular mecha-
nisms of DIM-D action are not yet clearly understood, it appears
to have potential as a therapeutic agent. Recently Katiyar et al
[46] also demonstrated that treatment of NHEK with silymarin
inhibits UVB-induced apoptosis of keratinocytes, and in this
process UVB-induced DNA damage was significantly reduced or
repaired after silymarin treatment.
Nurr1 is known to play important role in regulating inflamma-
tory disease. The inflammatory response contributes to the
Figure 5. Expression of Nurr1 and 8-OHdG in NHEK cells by immunocytochemistry and further confirmation by western blot. (A)
Immunocytochemical peroxidase staining of Nurr1 and 8-OHdG in NHEK cells treated with DIM-D and EGCG. Presence of brown stain indicated
positive staining for the primary antibody. (B)&(C) Western blot analysis of expression of Nurr1 in comparison to the control b-actin in Dim-D and
EGCG treated NHEK cells. Untreated cells were maintained as control. Data are calculated from triplicate experiments and presented as mean6 SD,
*P,0.05, **P,0.01 compared with control.
doi:10.1371/journal.pone.0069519.g005
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pathogenesis of the sunburn reaction, photocarcinogenesis, pho-
toaging of the skin and UV-induced immune suppression [47].
Nurr1 is induced by atherogenic stimuli in macrophages and
smooth muscle cells and is found in atherosclerotic plaques [42].
In the current study, western blot and immunocytochemical
analysis showed that in UVB irradiated NHEK cells, expression of
Nurr1 was significantly induced in DIM-D and EGCG treated
cells but expression was higher in DIM-D treated cells. According
to Bensinger&Tontonoz, examination of isolated microglia and
astrocytes demonstrated that Nurr1 potently influences inflamma-
tory gene expression in these cells [48]. Measurement of the levels
of 8-OHdG is used as a biomarker of oxidative stress [49]. The
molecular marker 8-OHdG expression was decreased after DIM-
D treatment, showing its superior activity of reducing UVB-
induced oxidative stress.
Nurr1 mediated signaling by DIM-D decreased UVB-induced
skin damage and may play vital role in complex pathways of cell
survival and apoptosis of cancer cells. Previous studies suggested
that DIM-D activates Nurr1 in human bladder cancer cells and
inhibits bladder tumor growth [28][3–4]. Therefore, it is expected
that Nurr1 mediated signaling by DIM-D would inhibit initiation
and promotion stages of UVB-induced photocarcinogenesis in
skin. Like silymarin, DIM-D may act as chemotherapeutic agents
by sensitizing tumors. In addition to its chemopreventive effects,
silymarin exhibits antitumor activity against human tumors (e.g.,
prostate and ovary) in rodents [50]. Likewise, our study also
suggests that DIM-D shows anticancer and chemopreventive
activities and more importantly this activity was superior to well
known natural anticancer compound EGCG. Therefore, the
mechanism involved in chemoprevention of DIM-D through
Nurr1 mediated signaling is novel and in future, will be confirmed
further by using Nurr1 deficient mice. The overall mechanism of
DIM-D suggested in this manuscript is the fact that DIM-D has
potential to induce inflammation, oxidative stress and apoptosis
which is evident in the induction of NFkB, CHOP and cleaved
caspase 3, in the skin cancer cells to result in death of the cancer
cells through the induction and mediation by the orphan nuclear
receptor, Nurr1. Our study also suggests that DIM-D is a potential
novel agent for developing chemopreventive strategies against
UVB induced skin cancer because of its significant reduction in
DNA damage and mutation and apoptosis of cells after UV
irradiation.
In summary, data from this study suggest that DIM-D may be
efficacious in treating skin cancer by acting as a potent and specific
stimulator of the Nurr1-mediated apoptosis in skin cancer cells.
Further studies are required to evaluate the chemopreventive
effects of DIM-D on skin cancer development using in vivo animal
models.
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